SOAT1 and lung carcinoma: It is worth mentioning that therapeutic strategies based on JAK/STAT inhibition have shown success in promoting apoptosis and anti-proliferative activities in SCC, suggesting that these pathways are the potential target sites for the treatment of lung cancers, including NSCLC and SCLC (He et al., 2004).